IBRI's Strategy
Today’s research is being driven by significant advances in our abilities to study complex disease processes and propose new ways to improve patients’ lives. To reflect the evolving nature of life sciences research and encourage synergies through collaboration, we’re enhancing our integrated capabilities and adding depth to how we approach patient-informed translational science.
Our focus on collaboration is enhanced by our unique position in Indianapolis’ 16 Tech, which is a 50-acre mixed-use innovation district that seeks to support and foster cross-sector collaboration, promote innovation and boost economic growth and prosperity. Our headquarters in 16 Tech serves as a nexus point that connects us within minutes to key collaborators at academic institutions, life sciences companies and biotechnology startups.